KDM1A and breast carcinoma: Overexpression of LSD1 has also been associated with unfavourable clinicopathological characteristics and poor prognosis in numerous tumors, such as hepatocellular carcinoma, colon cancer, breast cancer, prostate cancer, and non-small cell lung cancer [4-8].